Eur Heart J:PCI围术期心梗常见并可影响预后

2013-02-17 Eur Heart J 医学论坛网 高晓方 译

    韩国学者的一项研究表明,在接受冠脉介入治疗(PCI)的患者中,围手术期心梗相对常见并且与死亡风险升高具有相关性。论文于2013年2月12日在线发表于《欧洲心脏杂志》(European Heart Journal)。   此项研究对来自于11项PCI研究的个体患者资料进行了汇总。纳入研究常规测定了围手术期肌酸激酶同工酶(CK-MB),并前瞻性采集了死亡率数据

心血管
 

  韩国学者的一项研究表明,在接受冠脉介入治疗(PCI)的患者中,围手术期心梗相对常见并且与死亡风险升高具有相关性。论文于2013年2月12日在线发表于《欧洲心脏杂志》(European Heart Journal)。

  此项研究对来自于11项PCI研究的个体患者资料进行了汇总。纳入研究常规测定了围手术期肌酸激酶同工酶(CK-MB),并前瞻性采集了死亡率数据。共有23,604例患者被纳入研究。

  结果显示,在11项PCI研究(23 604例)中有7.1%(1677例)的患者发生围手术期心梗。围手术期心梗的最常见机制为侧枝闭塞。老年、女性、糖尿病、高血压、肾功能不全、多血管病变、左前降支病变、左主干病变、分叉部位病变、长病变、药物洗脱支架和支架数量为围手术期心梗的独立预测因素。随访时间介于1至5年之间。与无围手术期心梗患者相比,初步分析显示出现围手术期心梗的患者死亡风险显著升高(危险比[HR] 1.47)。对基线变量进行校正之后,围手术期心梗与死亡风险升高具有相关性(HR 1.20)。


Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention

Aims 
Peri-procedural myocardial infarction (MI) is a not infrequent complication of percutaneous coronary intervention (PCI), but conflicting information exists regarding incidence and prognostic impact of this event. We investigated frequency, causes, predictors, and clinical relevance of peri-procedural MI, using a large database.
Methods and results 
We pooled individual patient-level data from 11 PCI studies in which peri-procedural creatine kinase-MB mass was routinely measured and mortality data were prospectively collected. Among 23 604 patients from 11 studies, 1677 {7.1% [95% confidence interval (CI) 6.8–7.5%]} had peri-procedural MI. The most common mechanism of peri-procedural MI was side-branch occlusion. Independent predictors of peri-procedural MI were older age, female gender, diabetes, hypertension, renal dysfunction, multivessel disease, left anterior descending artery disease, left main disease, bifurcation lesion, long lesion, drug-eluting stents, and number of stents. Follow-up varied from 1 year to 5 years. In a crude analysis, patients with peri-procedural MI had significantly a higher risk of mortality than those without peri-procedural MI [hazard ratio (HR) 1.47; 95% CI 1.24–1.74]. After adjustment for baseline covariates, peri-procedural MI was associated with an increased risk of mortality (HR 1.20; 95% CI 1.04–1.39).
Conclusion 
Among patients undergoing PCI, the occurrence of peri-procedural MI measured by CK-MB mass assay was ∼7%, and more than half of cases were associated with side-branch occlusion. Several higher risk patients, lesions, and procedural characteristics were independent predictors of peri-procedural MI. Peri-procedural MI was associated with an increase in mortality.

    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1275352, encodeId=932c12e535215, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355730, encodeId=074b1355e304b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562137, encodeId=fa50156213e9b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1275352, encodeId=932c12e535215, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355730, encodeId=074b1355e304b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562137, encodeId=fa50156213e9b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
    2013-02-19 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1275352, encodeId=932c12e535215, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355730, encodeId=074b1355e304b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562137, encodeId=fa50156213e9b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
    2013-02-19 slcumt

相关资讯

NEJM:PCI +更佳药物疗法与单纯更佳药物疗法治疗稳定型冠状动脉疾病的比较

  背景  稳定型冠脉疾病患者的首选初始治疗是最佳药物治疗。我们假设在根据血流储备分数(FFR)测量确定的冠状动脉功能上明显狭窄的患者中,经皮冠脉介入术(PCI)加最佳药物治疗优于单纯最佳药物治疗。   方法  在考虑进行PCI 的稳定型冠脉疾病患者中,我们通过测量FFR评估了所有狭窄。至少有一处功能上明显狭窄(FFR≤0.80)的患者被随机分为两组,第一组接受FFR指导的P

CATHETER CARDIO INTE:SCAI 特设性PCI介入治疗共识声明

       2012年11月29日,美国心血管造影和介入学会发布介入治疗新共识文件,该共识建议,在血管造影后,治疗医师应在稳定性冠状动脉疾病开始治疗前先与患者及心脏治疗小组其他成员进行治疗讨论。该共识在线发表于11月29日的《导管插入和心血管介入》杂志上。        共识文件主笔James Blanke

JACC:冠脉搭桥术后药物二级预防少于PCI

  美国一项比较行冠脉搭桥术(CABG)和经皮冠脉介入治疗(PCI)后循证二级预防药物治疗的研究显示,血运重建术后第一年,行CABG的患者进行循证二级预防药物治疗者似乎更少。该研究2012年12月12日在线发表于《美国心脏病学会杂志》(J Am Coll Cardiol)。   冠脉血运重建后心脏保护药物的使用情况相对不佳,且在各个研究中并不一致。研究者对一个大型综合医疗服务系统中因新发冠

NEJM:糖尿病伴冠脉疾病患者行CABG优于PCI(FREEDOM研究)

     期待已久的FREEDOM研究(糖尿病患者未来血运重建评估:多支病变最佳治疗)结果于11月4日公布。该研究表明,接受冠状动脉旁路移植术(CABG)治疗的糖尿病伴多支冠状动脉疾病患者在全因死亡率、非致命性心梗和非致命性卒中方面显著低于接受经皮冠状动脉介入(PCI)治疗者。研究结果同时公布于美国心脏学会(AHA)2012科学年会及《新英格兰医学杂志》。   该研究共纳入1900

JACC:美国研究揭示CABG后二级预防不足

    美国一项研究报告,患者在接受冠状动脉旁路移植术(CABG)或经皮冠状动脉介入治疗(PCI)术后1年内,应用二级预防药物的依从性欠佳,且CABG术后患者二级预防依从性更差。研究12月12日在线发表于《美国心脏病学会杂志》(J Am Coll Cardiol)。   该研究选取2000年~2007年大型综合卫生保健服务系统中因新发冠心病接受初始CAB

Circulation:IABP,为高危PCI护航

  英国BCIS-1(球囊泵辅助冠状动脉干预研究-1)最新分析结果提示,对于严重缺血性心脏病接受经皮冠脉介入治疗(PCI)的患者,使用主动脉内球囊反搏(IABP)可显著降低患者的全因死亡率。文献于12月6日在线发表于《循环》(Circulation)杂志。   研究简介   BCIS-1研究是一项前瞻性、随机对照研究,共纳入301例左心功能障碍(左室射血分数<30%)和严重冠脉疾病的患者